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Background: Junctional vascular trauma such as that at the thoracic outlet poses particular challenges in surgical manage-
ment. The use of endovascular techniques for such injuries is attractive as repair may be facilitated without the need for
thoracotomy; however, the utility of such techniques is currently based on opinion, small retrospective series, and literature
reviews of narrative and not systematic quality. The objective of this study is to provide a complete and systematic analysis of
the literature pertaining to open surgery (OS) and endovascular management (EM) of thoracic outlet vascular injuries.
Methods: An electronic search using the MEDLINE, Embase, Cochrane Library, Science Citation Index, and LILACS
databases was performed for articles published from 1947 to November 2011. The review conformed to the Preferred
Reporting Items for Systematic Reviews and Meta-analyses statement standards. Prospective studies and retrospective
cohorts of more than 10 patients were included. The primary outcome was all-cause mortality.
Results: One prospective noncomparative study and 73 retrospective series met the inclusion criteria. There were no
randomized studies. All studies were at high risk of bias. Fifteen studies described outcomes for both OS and EM (549
patients). The majority of these studies described EM for traumatic arteriovenous ﬁstulas or false aneurysms in stable
patients. Direct comparison between OS and EM was possible in only three studies (comprising 23 OS and 25 EM
patients), which showed no difference in all-cause mortality (odds ratio, 0.67; 95% conﬁdence interval [CI], 0.11-4.05),
but a shorter operating time with EM (mean difference [ 58.34 minutes; 95% CI, 17.82-98.85). These three series
included successful EM of unstable patients and those with vessel transection. There were 55 studies describing only OS
(2057 patients) with a pooled mortality rate of 12.4% (95% CI, 9.9%-15.2%). Four studies described only EM (101
patients) with a pooled mortality rate of 26% (95% CI, 8%-51%), but these represented a distinct subgroup of cases
(mainly iatrogenic injuries in older patients).
Conclusions: The current evidence is weak and fails to show superiority of one modality over the other. EM is currently
used primarily in highly selected cases, but there are reports of a broader applicability in trauma. High-quality
randomized studies or large-scale registry data are needed to further comment on the relative merits or disadvantages
of EM in comparison to OS. (J Vasc Surg 2013;57:547-67.)Trauma is the leading cause of death in young people,
and trauma-related morbidity results in signiﬁcant health
care economic costs.1 Vascular injury constitutes 3%-5%
of modern civilian trauma, but is highly morbid with the
potential for rapid deterioration.1-3
Upper-extremity junctional vascular injuries such as
those at the thoracic outlet pose particular challenges in
surgical management as adequate access may mandate
extensive incisions.2,4 The use of endovascular techniques
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://dx.doi.org/10.1016/j.jvs.2012.10.077be facilitated without the need for thoracotomy or other
complex thoracic outlet exposure, whereas late stent
graft–related complications may not necessarily prejudice
further attempts at revascularization, often in less emergent
circumstances.2,5
Despite the theoretical advantages of endovascular
management (EM), it is notable that supporting clinical
evidence is of poor quality, with expert opinion based
primarily on small retrospective series and literature reviews
of narrative rather than systematic quality.1-3,5-7 Current
areas of controversy include the relative roles of EM in
comparison to open surgery (OS). Thus, the traditional
view that EM is an adjunctive treatmentwith particular appli-
cability to iatrogenic injuries and late complications of injury
(such as false aneurysms and arteriovenous ﬁstulas) is increas-
ingly challenged by those who consider damage control in
a trauma setting to be within the remit of EM.1,5,7 In addi-
tion, there remains concern about the long-term durability
of stent grafts and the implications of this on long-term
outcomes after EM of traumatic vascular injuries.5,7
The aim of this systematic review and meta-analysis of
all published data for thoracic outlet vascular injuries was547
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EM.
METHODS
A computer-assisted search was performed (from 1947
to November 2011) of the medical databases MEDLINE,
Embase, Science Citation Index, Cochrane Library, and
LILACS using the keywords subclavian, axillary, supra-
aortic, brachiocephalic, shoulder, and upper extremity in
combination with the terms puncture, laceration, and tran-
section, and the exploded Medical Subject Heading
(MeSH) term wounds and injuries. After relevant titles
were identiﬁed, abstracts of these studies were indepen-
dently read by two of the authors (S.S. and B.P.). Articles
printed in languages other than English were translated
using Google Translate. The literature review conformed
to the Preferred Reporting Items for Systematic Reviews
and Meta-analyses (PRISMA) statement standards.8 The
PRISMA statement, in a manner analogous to the Consol-
idated Standards of Reporting Trials (CONSORT) state-
ment for randomized controlled trials, seeks to improve
the reporting quality (and, therefore, methodological
aspects) of systematic reviews (eg, through the use of inde-
pendent dual data extraction, publication of reproducible
search strategies, and objective assessments of bias among
included studies).
Clinical studies were eligible for inclusion if they
described patient cohorts with injuries to the major arteries
of the thoracic outlet (ie, axillosubclavian, brachiocephalic,
and common carotid arteries), details of the treatment they
received, and the primary outcome (all-cause mortality) for
the patients of interest. Eligible study types were random-
ized trials, nonrandomized comparative studies, prospec-
tive observational studies, and retrospective observational
studies with more than 10 patients for at least one of the
three types of arteries. Articles combining axillary artery
and subclavian artery trauma were included provided they
contained more than 10 patients for each artery type, but
series focused solely on distal axillary artery trauma or on
cervical carotid injuries were excluded as these cases can
usually be managed with extrathoracic incisions. We
excluded review papers, editorial and commentary pieces,
single case reports, and case series with 10 or fewer
patients. Studies presenting supra-aortic injuries within
larger series of arterial trauma were excluded if they did
not report treatment and outcomes speciﬁc to the patient
cohort of interest, as were articles purely on cervicomedias-
tinal venous injuries. Multiple publications from the same
center were assessed, and only the most recent article was
included if it appeared that the papers shared proportions
of the patient populations. Randomized studies were
assessed for risk of bias using validated Cochrane method-
ology.9 The quality of these nonrandomized studies was
scored using a checklist composed of validated criteria.10
Nonrandomized studies were assumed to be at high risk
of bias unless they achieved maximum scores on the criteria
assessed (ie, 17/17 for comparative studies and 16/16 for
noncomparative studies). Quality of evidence was tabulatedusing GRADEpro (GRADE-Proﬁler software Version 3.6,
GRADE Working Group).
Data were extracted on patient demographics (age,
gender), mechanism of injury (penetrating, blunt and iatro-
genic), associated injuries, and the nature of treatment (OS
or EM). The primary outcome of interest was all-cause
mortality. Secondary outcomes were postoperative stroke
rates and upper extremity amputation, failures of EM
requiring conversion to open, transfusion requirements or
blood loss, reinterventions, hospital length of stay, and
late outcomes (both surrogate outcomes such as stent/
graft patency rates and patient-reported outcomes such
as quality-of-life scores and time to return to normal
activities).
For comparative studies, data analysis was performed
using RevMan 5.1 (Review Manager Version 5.1;
Cochrane Collaboration). Pooled odds ratios were calcu-
lated for discrete variables (eg, mortality). Weighted
mean difference was calculated for continuous variables
(eg, length of stay and blood loss). For noncomparative
studies, outcomes were analyzed using a meta-analysis of
proportion calculation (StatsDirect statistical software,
Version 1.0; StatsDirect, Altrincham, UK). Pooled propor-
tions were determined using random effects models as
described by DerSimonian and Laird.11 Pooled odds ratios
(OR) were determined using the Mantel-Haenszel random
effects model. The inverse-variance random effects model
was used to analyze count data and continuous variables.
Heterogeneity among studies was assessed by the Higgins’
I2 inconsistency test (and the Cochran Q statistic for meta-
analyses of proportions or the c2 statistic for meta-analyses
of comparative studies), a null hypothesis test in which P <
.05 is taken to indicate the presence of signiﬁcant heteroge-
neity. The Egger test was used to assess funnel plots for
signiﬁcant asymmetry (indicative of possible publication
bias).
RESULTS
A total of 18,420 articles were identiﬁed from electronic
searching. An example of the results from a single database
(MEDLINE) is shown in Supplementary Table I (online
only). Seventy-four studies were identiﬁed that met the
inclusion criteria. Fig 1 is a ﬂow diagram for included
and excluded studies. There were no randomized studies.
There was one prospective noncomparative trial assessing
the use of covered stents for traumatic vascular injury.12
An additional ﬁve studies described prospective collection
of data within a registry but were, nonetheless, retrospective
reviews.13-18 Thus, the single prospective and 73 retro-
spective studies could be subdivided into three groups:
studies that described patient cohorts undergoing both
OS and EM (n ¼ 15),4,13,14,19-30 studies describing patient
cohorts undergoing only EM (n ¼ 4),12,18,31,32 and
studies describing patient cohorts undergoing only OS
(n ¼ 55).15-17,33-84
Quality of included studies. None of the included
studies achieved maximum scores, and thus, all were deter-
mined to be at high risk of bias. The speciﬁc criteria used
Fig 1. Systematic search results.
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“no,” or “unclear” for each are listed as supplementary infor-
mation in Supplementary Tables II-IV (online only).
Particular deﬁciencies related to baseline imbalance and
lack of blinding for studies describing both OS and EM,
nonconsecutive patient selection for EM case series, and
inadequate follow-up for OS case series.
Studies describing both OS and EM. The 15 studies
describing both treatment modalities involved 581 patients
with 582 primary injuries (Table I). Patient characteristics
were similar across most studies, with a predominance of
young male patients, although it was noted that reports
included both means and medians for age (Table II). One
study did not report patient demographics.30 Six studies
described a proportion of patients managed nonoperatively
(17 patients).5,21-24,27 Furthermore, one study described
outcomes for only 5 of 16 OS patients who were felt to
have had injuries amenable to EM, and another described
ﬁve patients who died in the emergency department without
elaborating on whether or not any surgical procedures were
performed (eg, resuscitative thoracotomy).21,23 Therefore,
the 15 studies described outcomes for 498 patients under-
going OS and 51 patients undergoing EM. Pooled results
for all 15 studies indicated an all-cause mortality rate of
13.3% (95% CI, 7.36%-20.67%; Fig 2, A), a stroke rate of
1.7% (95% CI, 0.8%-2.95%; Fig 2, B), and an amputation
rate of 1.48% (95% CI, 0.62%-2.72%; Fig 2, C). For the
primary outcome (mortality), there was evidence of both
statistical heterogeneity (Cochran Q ¼ 75.8, P < .0001;
I2 ¼ 81.5%, 95% CI, 69.6%-87.4%) and publication bias
(Egger test ¼ 2.95, P ¼ .0041).For 12 of the 15 studies, it was evident that there
was baseline imbalance in clinical characteristics between
the patients undergoing OS and those undergoing
EM.13,14,19,20,22,24-30 EM in these studies was restricted
to hemodynamically stable patients and stenting in those
with arterial contusions (one case), arterial dissection
(one case), arteriovenous ﬁstulas (six cases) or false aneu-
rysms (nine cases), embolization of bleeding side
branches/false aneurysms (seven cases), or balloon occlu-
sion as a temporizing measure prior to deﬁnitive surgery
(two cases). Given the degree of imbalance, it was felt inap-
propriate to compare pooled outcomes for these 12
studies.
For three studies, sufﬁcient data were provided for
patients in both cohorts to allow direct comparison
between the groups (comprising 23 OS and 25 EM
patients) (Table III). These series contained successful
EM cases in the context of hemodynamic instability (six
cases) or vessel transection (one case). Weighted compar-
ison of the three studies for all-cause mortality did not
show any difference between OS and EM (OR, 0.67;
95% CI, 0.11-4.05). There was no evidence of statistical
heterogeneity (c2 ¼ 0.98, P ¼ .61; I2 ¼ 0%), but there
were too few studies to comment on the presence or
absence of publication bias. Sensitivity analysis, which
excluded the three cases of iatrogenic injury contributed
by Xenos et al,21 did not change the result (OR, 1.14;
95% CI, 0.13-9.84).
Results were not pooled for stroke or amputation rates
as there were too few events (zero strokes and one ampu-
tation). Two of the three studies also provided data on
Table I. Demographics of studies describing both open surgery (OS) and endovascular management (EM)
Reference Year Country Type of injury
Any
iatrogenic
injuries?
Total
number
of patients
Prichayudh et al19 2009 Thailand pen 13%
blunt 87%
Unclear 15
Lederman et al20 2005 Brazil pen 75%
blunt 25%
No 20
Xenos et al21 2003 United States pen 52%
blunt 48%
Yes 27d
Danetz et al13 2005 United States pen 100% No 46
Shalhub et al4 2011 United States blunt 100% No 34f
Kalakuntla et al22 2000 United States pen 100% No 25g
Carrick et al23 2010 United States pen 80%
blunt 20%
No 15h
Demetriades et al24 1999 United States pen 100% Unclear 79i
Du Toit et al25 2008 South Africa pen 100% No 39
Sobnach et al14 2010 South Africa pen 100% No 50
Klocker et al26 2010 Austria blunt 100% No 38
Pretre et al27 1994 France blunt 100% No 13l
Robbs et al28 1981 South Africa pen 100% No 104
Abouljoud et al29 1993 United States pen 93%
blunt 7%
No 28
Rao et al30 1993 United States pen 100% No 48
ax-sub, Axillosubclavian; bch, brachiocephalic/innominate; car, carotid; NFS, not further speciﬁed; pen, penetrating; prim rep, primary repair; pros recon,
reconstruction with prosthetic material; PTFE, polytetraﬂuoroethylene; resus thorac, resuscitative thoracotomy or sternotomy only; vein recon, vein recon-
struction; vert, vertebral.
aRefers to primary injury as deﬁned by authors.
bScored as “yes” if sternotomy or thoracotomy was used for any of the OS cases.
cDeath, all cause death; stroke, only new postoperative stroke; amputations, exclude those explicitly described as secondary to neurological sequelae of brachial
plexus injury and primary amputation for trauma.
dStudy described 27 patients in total: four were managed nonoperatively, seven underwent EM, and 16 underwent OS; but outcomes only reported by authors
for 5 of 16 OS patients judged to have lesions amenable to EM.
eIncludes ﬁve isolated axillosubclavian venous injuries.
fStudy described 34 patients in total, six managed nonoperatively.
gStudy described 25 patients in total, two managed nonoperatively.
hStudy described 15 patients in total; ﬁve died in emergency room (unclear if a thoracotomy was performed), two managed nonoperatively.
iStudy described 79 patients in total, two managed nonoperatively.
jIncludes 20 isolated axillosubclavian venous injuries.
kOne conversion to OS.
lStudy described 13 patients with 14 injuries, one of whom was managed nonoperatively.
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OS EM
Outcomes c
Groups
comparable?
No.
of patients
No.
of injuriesa
Sternotomy or
thoracotomy
used?b
Details of
treatment
No.
of patients
No. of
injuriesa
Details of
treatment
14 14 ax-sub Yes 21% prim rep
50% vein recon
21% pros recon
8% ligation
1 1 ax-sub 1 stent graft NFS 0% death
0% stroke
21% amputation
No
16 16 ax-sub Yes 19% prim rep
69% vein recon
6% ligation
6% resus thorac
4 4 ax-sub 4 stent grafts NFS 20% death
0% stroke
5% amputation
No
5 5 ax-sub Not stated 25% prim rep
75% vein recon
7 6 ax-sub
1 vert
7 Wallgraft stents 17% death
0% stroke
0% amputation
Yes
43 43 ax-sube Yes 21% prim rep
28% vein recon
21% pros recon
9% ligation
21% resus thorac
3 3 ax-sub 2 embolizations
1 balloon
25% death
0% stroke
0% amputation
No
16 7 ax-sub
9 bch
Yes 12% prim rep
23% vein recon
53% pros recon
12% ligation
12 11 ax-sub
1 bch
6 Viabahn stents
1 Wallgraft stent
1 stent graft NFS
1 balloon
3 converted to open
9% death
0% stroke
3% amputation
Yes
22 22 ax-sub Yes 45% prim rep
9% vein recon
32% pros recon
14% ligation
1 1 ax-sub 1 stent graft NFS 4% death
0% stroke
0% amputation
No
2 2 ax-sub Not stated 50% pros recon
50% ligation
6 6 ax-sub 2 Wallgraft stents
3 stent grafts NFS
1 converted to open
53% death
0% stroke
0% amputation
Yes
76 76 ax-subj Yes 25% prim rep
24% vein recon
29% pros recon
24% resus thorac
1 1 ax-sub 1 covered stent graft NFS 34% death
0% stroke
0% amputation
No
34 34 bch Yes 50% prim rep
44% recon NFS
6% ligation
5 5 bch 5 Wallgraft stentsk 21% death
5% stroke
0% amputation
No
49 49 ax-sub Yes 53% prim rep
18% vein recon
22% pros recon
6% ligation
1 1 ax-sub 1 PTFE-covered stent graft 0% death
0% stroke
0% amputation
No
34 34 ax-sub Not stated 15% prim rep
85% recon NFS
4 4 ax-sub 4 stent grafts NFS 3% death
0% stroke
3% amputation
No
12 10 ax-sub
2 bch
Yes 38% prim rep
38% vein recon
8% pros recon
15% ligation
1 1 ax-sub 1 balloon 8% death
0% stroke
0% amputation
No
103 48 ax-sub
51 car
4 vert
Yes 54% prim rep
17% vein recon
1% pros recon
7% recon NFS
20% ligation
1 1 car 1 embolization 8% death
3% stroke
1% amputation
No
27 13 ax-sub
3 bch
10 car
1 vert
Yes 59% prim rep
19% vein recon
11% pros recon
11% ligation
1 1 vert 1 embolization 7% death
7% stroke
0% amputation
No
45 9 ax-sub
29 car
7 vert
Yes 58% prim rep
2% vein recon
13% pros recon
27% ligation
3 3 vert 3 embolizations 21% death
2% stroke
0% amputation
No
Table I. Continued.
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Table II. Characteristics of patients in studies describing
both open surgery (OS) and endovascular management
(EM)
Reference Male, % Mean age, years
Prichayudh et al19 87 26
Lederman et al20 85 29.2
Xenos et al21 60 33.3
Danetz et al13 91 29
Shalhub et al4 79 33a
Kalakuntla et al22 80 30
Carrick et al23 93 31.7
Demetriades et al24 83.5 32
Du Toit et al25 92 27
Sobnach et al14 98 27
Klocker et al26 Unclearb Unclearb
Pretre et al27 85 25a
Robbs et al28 91 28
Abouljoud et al29 71 39
Rao et al30 Not stated Not stated
aMedian.
bResults are not separable from those for other distal upper extremity arterial
injuries.
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results suggesting a statistically shorter operating time
with EM (mean difference ¼ 58.34 minutes; 95% CI,
17.82-98.85 minutes), but no difference in blood loss
(mean difference ¼ 458.50 mL; 95% CI, 396.26-
1313.25 mL).4,21 One of the three studies reported on
length of hospital stay (LOS): medial LOS for the OS
group was 29 days; for the EM group, 19 days; and for
EM converted to open, 17 days.4 One of the 12 studies
with imbalanced groups reported on transfusion require-
ments and LOS for a subgroup of patients: (for the stable
OS group, mean transfusion ¼ 6 units of packed red cells
and mean LOS ¼ 8.6 days versus 0 units and 2 days for
the EM group).25 This study was not included in pooled
analyses as demographic data for the OS subgroup were
not presented.
Three studies reported EM cases that failed or were con-
verted to open (seven cases) for the following reasons: failure
to exclude pseudoaneurysm because of inadequate landing
zone (one case), failure to traverse transected or occluded
artery (four cases requiring surgery, one case managed by
temporary balloon occlusion), and inadvertent coverage of
the common carotid artery requiring carotid-subclavian
bypass (one case).4,23,25 Therewere two additional EMcases
requiring late reintervention: one carotid-subclavian bypass
at postoperative day 5 for a type I endoleak (inadequate
proximal seal because of proximity to the common carotid
artery), and one carotid-axillary bypass at 9 months for arm
claudication caused by stent thrombosis.4,21 There were
three further reports of temporary balloon occlusion: two
cases prior to deﬁnitive surgery and one case prior to stent
graft deployment.13,23,27 Comparison of stent patency rates
was hampered by variability in reporting, but studies vari-
ously reported rates of 100% at 1 year, 80% at 9 months,
and 75% at a median follow-up of 5.1 years.4,21,26 Two
studies reported 100% patency of open repairs during thestudy periods, whereas three studies reported graft oc-
clusions requiring redo reconstruction (three cases) or
resulting in amputation (one case).4,13,21,22,26All seven cases
of upper-extremity amputation were in patients under-
going OS.
Follow-up reporting was very variable; 10 of 15 studies
did not report on losses to follow-up, and 8 of 15 did not
report on length of follow-up. Only 3 of 15 studies re-
ported no loss to follow-up over periods ranging from
a mean of 26.1 weeks to a median of 18 months.13,21,27
The longest reported period of follow-up at study level
was a median of 5.1 years (range, 0.5-19.7 years).26 No
studies reported any formal patient-reported outcomes
(such as quality-of-life scores).
Studies describing only EM. The four studies
describing only EM involved 101 patients with 101 primary
injuries (all axillosubclavian) and described a spectrum of
EM options including stent grafting, balloon occlusion,
and percutaneous closure devices (Table IV). Two of the
studies were on treatment of arterial injury from inadvertent
central venous line puncture, and a third stated that 78% of
the entire cohort (which included femoral and iliac injuries)
were iatrogenic injuries but did not provide details speciﬁc
to the subclavian artery subgroup.12,31,32 The fourth study
described noniatrogenic penetrating trauma.18 All four
studies excluded some patients (ie, described nonconsecu-
tive series), and none provided any objectiﬁed measures of
patient comorbidity (such as trauma/injury scores, Amer-
ican Society of Anesthesiologists grading, or proportions
with hypotension). For the three studies on iatrogenic
injuries, the patient demographic was older with a higher
female proportion.12,31,32 The pooled all-cause mortality
rate was 26% (95% CI, 8%-51%; Fig 3). There was evidence
of statistical heterogeneity (CochranQ¼ 17.08, P¼ .0007;
I2 ¼ 82.4%, 95% CI, 35%-91.5%), but not publication bias
(Egger test ¼ 3.35, P ¼ .064) among studies.
All four studies reported follow-up. The prospective
study reported survival analysis for subclavian stent grafts,
with a late exclusion success rate of 90.0% at 1 year,
primary patency of 85.7% at 1 year, and freedom from
target lesion revascularization of 77.1% at 1 year. The three
retrospective studies reported mean follow-up periods of
14.8, 27.3, and 49 months, with attrition rates of 0, 7.7,
and 55%, respectively. For the three studies, the clinical
success rate (successful treatment of lesion without the
need for surgery) was 100%, and the primary technical
success rate (successful treatment of the lesion at the ﬁrst
attempt) was 92.8%. Early (within 30 days) stent occlusion
was reported in three cases (all successfully treated with
catheter-directed thrombolysis), late in-stent stenosis in
ﬁve cases (all successfully treated with angioplasty), and
late stent occlusion in three cases (all managed conserva-
tively)—all by the same study.18
Subgroup analysis for EM cohort (studies including
iatrogenic injuries). Heterogeneity was reduced in
subgroup analysis of the three studies predominantly on iatro-
genic injuries when pooled analysis gave an all-causemortality
rate of 36% (95% CI, 16%-58%). Of the 19 reported deaths,
Fig 2. Meta-analyses of (A) mortality rates, (B) stroke rates, and (C) amputation rates for studies reporting both open
surgery (OS) and endovascular management (EM).
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none of the 19 deaths were explicitly linked to the vascular
injury or subsequent EM. No studies reported on LOS or
patient-related outcome measures.
Studies describing only OS. The 55 studies de-
scribing only OS involved 2062 patients with 2110 primary
injuries (1487 axillosubclavian arteries, 144 brachioce-
phalic/innominate arteries, 237 carotid artery injuries, 24
vertebral artery injuries, ﬁve ascending aortic/arch injuries,
and 213 isolated cervicomediastinal venous injuries)
(Table V). Of the 2057 patients (ie, excluding the ﬁve
patients with ascending aortic/arch injuries), 82 were
managed conservatively. Although there was variability in
reporting, the 55 series generally described noniatrogenic
injuries (79% penetrating, 20% blunt, 1% iatrogenic) in a
younger and predominantly male population. The majority
of studies (37/55) described treatment in a proportion of
patients who were hemodynamically unstable, and thisproportion was median 39% (interquartile range, 20%-
50%). The pooled all-cause mortality rate was 12.4% (95%
CI, 9.9%-15.2%), the stroke rate was 1.2% (95% CI, 0.8%-
1.7%), and the amputation rate was 1.3% (95% CI, 0.8%-
1.9%). For the primary outcome (mortality), there was
evidence of both statistical heterogeneity (Cochran Q ¼
169.02, P < .0001; I2 ¼ 68.1%, 95% CI, 56.8%-75.3%)
and publication bias (Egger test ¼ 1.90, P < .0001).
Four studies reported on blood loss, with three reporting
mean losses of 3500, 6663, and 3254 mL and the fourth
giving a range of 600-2400mL.37,38,44,76 Another six studies
reported on blood transfusion requirements, with mean
values of 4.8, 12.4, 18, 14, 4.5, and 8.9 units.40,42,46,51,59,82
Two studies reported on LOS, stating mean durations
of 6.3 and 40.4 days.40,46 No studies reported formally
on patient-related outcome measures, although there was
near-universal agreement on the poor functional result of
brachial plexus injury in conjunction with axillosubclavian
Table III. Demographics of the three studies with comparable open surgery (OS) and endovascular management (EM)
cohorts
Reference
OS
No. Age/gender a Type of injury Trauma score b Shock,c % Pathology treated
Xenos et al21 5 34/80% pen 40%
blunt 60%
TS 12 (10-12) 0% bleed 20%
pseudoan 40%
dissection 40%
Shalhub et al4 16 Uncleare blunt 100% ISS 29 (15.5-34) 44% pseudoan 50%
trans/lac 44%
occlusion 6%
Carrick et al23 2 26/100% pen 100% ISS 11 (9-13) 100% bleed 100%
AVF, Arteriovenous ﬁstula; bleed, side-branch bleeding; iatro, iatrogenic; pen, penetrating; pseudoan, pseudoaneurysm; trans/lac, transection/laceration.
aMedian age in years/proportion male.
bTrauma score given as median Trauma Score (TS, not further speciﬁed by authors) or Injury Severity Score (ISS) þ IQR.
cShock however deﬁned by authors of study.
dBased on four patients only (no trauma score for three patients with iatrogenic injury).
eUnable to separate OS cohort data from those for nonoperatively managed cohort (n ¼ 6). Demographics for entire group (OS, EM , and nonoperative
management): median age 33 (range, 14-78), 80% male.
fAll endovascular interventions delivered percutaneously (ie, no cut-downs required).
Table IV. Characteristics of studies describing only patients who underwent endovascular management (EM)
Reference Year Country
No. of
patients
No. of
injuries a
Patient age and
gender b Type of injury
Trauma
score e Shock,f %
White et al12 2006 United States 18 18 ax-sub UCc UCd NS NS
Yu et al31 2011 United States 13 13 ax-sub median 50y/46% 100% iatro NS NS
du Toit et al18 2008 South Africa 57 57 ax-sub mean 34y/91% 100% pen NS UC
Chemelli et al32 2010 Austria 13h 13 ax-sub mean 68.5y/62% 100% iatro NS UC
ax-sub, Axillo-subclavian; AVF, arteriovenous ﬁstula; bch, brachiocephalic/innominate; bleed, side-branch bleeding; car, carotid; CLI, critical limb ischemia;
CTD, connective tissue disease; fem, femoral; iatro, iatrogenic; N/A, not applicable; NFS, not further speciﬁed; NS, not speciﬁed; OS, open surgery;
pen, penetrating; perc, percutaneous; trans/perf, transection/perforation/laceration/rupture/puncture; pseudoan, pseudoaneurysm; UC, unclear; vert,
vertebral.
aRefers to primary injury as deﬁned by authors.
bMean or median age (years) as speciﬁed by the authors, gender given as male proportion (%).
cNot speciﬁed for subclavian cohort e entire group (including iliac and femoral injuries, n ¼ 62), mean age 61.6 years and 69.4% male.
dNot speciﬁed for subclavian cohort e for entire group, 78% were iatrogenic.
eHowever deﬁned by the authors.
fShock however deﬁned by the authors.
gAll outcomes analysed as intention-to-treat, death ¼ all-cause death, stroke includes only new postoperative stroke, amputation (amp) excludes that explicitly
described as secondary to neurological sequelae of brachial plexus injury and primary amputation for trauma.
hStudy described a total of 17 patients e four underwent OS but no outcomes presented for this group.
jFour patients received more than one type of treatment.
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EM
No. Age/gender a Type of injury Trauma score b Shock,c % Pathology treated
7 32/43% pen 43%
blunt 14%
iatro 43%
TS 9.5 (6.5-12)d 14% bleed 20%
pseudoan 43%
AVF 43%
12 33.5/83% blunt 100% ISS 25.5 (18.3-39) 50% pseudoan 8%
trans/lac 17%
occlusion 75%
6f 23/100% pen 67%
blunt 33%
ISS 13 (13-36) 17% bleed 17%
pseudoan 17%
trans/lac 17%
Not stated 49%
Table III. Continued.
Type of pathology Details of treatment EM access Outcomes g Comments/exclusions
5/18 (28%) trans/perf
2/18 (11%) AVF
9/18 (50%) pseudoan
2/18 (11%) dissection
18 Wallgraft stents NS 3/18 (17%) death
0/18 (0%) stroke
0/18 (0%) amp
Prospective study (industry funded)/
excluded patients <50, unﬁt patients,
contaminated wounds, patients with
CTD or unable to take antiplatelets/
anticoagulation, lesions crossing joints
13/13 (100%) trans/perf 13 balloon occlusion fem perc 5/13 (38%) death
0/13 (0%) stroke
0/13 (0%) amp
Retrospective/nonconsecutive series (two
patients excluded e one stent and one
arterial closure device)
42/57 (74%) pseudoan
12/57 (21%) AVF
3/57 (5%) occlusion
20 Wallgraft stents
9 Hemobahn stents
27 Fluency stents
1 custom Palmaz stent
fem perc 4/57 (7%) death
0/57 (0%) stroke
0.57 (0%) amp
Retrospective (prospective data
collection)/nonconsecutive series
(excluded patients with active
“uncontrollable” bleeding, CLI, brachial
plexus/airway compression, contaminated
wounds, concurrent aero-digestive injury
and proximal/distal luminal discrepancy)
13/13 (100%) trans/perf 5 balloon occlusionj
3 Fluency stents j
1 Wallgraft stent j
6 Angio-Seal closure j
fem NFS 7/13 (54%) death
0/13 (0%) stroke
0/13 (0%) amp
Retrospective/nonconsecutive series
(excludes four patients who underwent
OS)
Table IV. Continued.
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Proportion meta-analysis plot [random effects]
White 0.17 (0.04, 0.41)
du Toit 0.07 (0.02, 0.17)
Yu 0.38 (0.14, 0.68)
Chemelli 0.54 (0.25, 0.81)
combined 0.26 (0.08, 0.51)
0.0 0.3 0.6 0.9
proportion (95% confidence interval)
Fig 3. Meta-analysis of mortality rates for studies reporting only endovascular management (EM).
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70% of studies did not provide information on attrition
rates, and in 80% of studies the length of follow-up was
either not clear or too short to exclude important effects
on outcomes. Only three studies provided 100% follow-
up over periods of 7.2, 36, and 24 months.43,48,61
Subgroup analysis for OS cohort (blunt and pene-
trating trauma). Heterogeneity persisted in subgroup
analysis of studies reporting only noniatrogenic penetrating
trauma (n ¼ 15, pooled mortality rate ¼ 12.9%, 95% CI,
6.9%-20.9%) and those reporting only noniatrogenic blunt
trauma (n ¼ 9; pooled mortality ¼ 11%; 95% CI, 5%-19%).
Subgroup analysis for OS cohort (studies pre-2000
and studies from 2000 onward). For studies published
prior to 2000 (n ¼ 49), the pooled mortality rate was
12.5% (95% CI, 9.9%-15.4%) and there was persistence of
both statistical heterogeneity and publication bias. For
studies published on or after 2000 (n ¼ 6), the pooled
mortality rate was 11.4% (95% CI, 3.4%-23.3%), and
although heterogeneity remained, the Egger test did not
suggest publication bias (Egger test ¼ 1.98; P ¼ .47).
There were no reports of postoperative stroke or amputa-
tions in the more recent cohort.
Quality of evidence. As elaborated in Supplementary
Tables V-VII (online only), the quality of evidence was
graded as very low.
DISCUSSION
This systematic review has shown that there is a large
body of poor-quality evidence regarding the beneﬁts ofOS and a much smaller amount of data regarding EM
in the management of thoracic outlet vascular injuries.
Although 15 studies described both types of treatment,
for the majority (12 of 15 studies), the use of EM was
restricted to highly selected cases (usually treatment of
hemodynamically stable patients with arteriovenous ﬁs-
tulas, false aneurysms, or bleeding side branches requiring
embolization). This ﬁnding was replicated in the majority
(3 of 4) of series reporting only EM which described
intervention for predominantly iatrogenic injuries. This
subgroup described a different patient demographic (older
patients with a higher female proportion) with a pooled
all-cause mortality rate of 36% (95% CI, 16%-58%). It is
postulated that the high all-cause mortality rate observed
reﬂects both the more complete follow-up in these studies
and the fact that the patients involved generally had
different disease characteristics (ie, chronic diseases such
as cancer and renal failure rather than acute pathology
such as trauma), and it should therefore be noted that
this result is not directly comparable to pooled mortality
results from the OS series. There were no reports of post-
procedure stroke in the EM series, which is reassuring
given the concerns with coverage of the ipsilateral verte-
bral artery when stenting the subclavian artery.85 The
authors of the large series on noniatrogenic injury stated
that coverage of the ipsilateral vertebral was frequently
performed provided the contralateral vertebral was not
atretic or hypoplastic.85 It is noteworthy that, in the
context of EM of aortic transection, expert opinion has
stated that a policy of selective rather than routine
JOURNAL OF VASCULAR SURGERY
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appropriate in cases where the left subclavian artery is
covered.86
Late stent graft–related complications were reported in
both prospective (22.9% requiring reintervention at 1 year)
and retrospective (14% late in-stent stenosis or occlusion)
studies. This is analogous to the reintervention rates re-
ported for patients who have undergone EM for aortic
transection.87 Reintervention rates for subclavian artery
stents may reﬂect problems related to stent compression
between the clavicle and ﬁrst rib in the mid-distal portion
of the artery, but the data from this systematic review are
not sufﬁciently robust to provide a deﬁnitive answer on
this issue.88 It is likely that the beneﬁts of EM for supra-
aortic trauma will need to be weighed against the burden
of more intensive postoperative surveillance in a situation
analogous to the use of endovascular aneurysm repair for
abdominal aortic aneurysms.89,90
Small numbers hampered a comparative analysis of the
relative merits of either treatment modality, since only
three studies (involving 48 patients) described broadly
comparable (but nonrandomized) cohorts of OS and EM
patients. Given this limitation, meta-analysis found no
difference in all-cause mortality between OS and EM
(OR, 0.67; 95% CI, 0.11-4.05). For secondary outcomes,
EM was associated with a shorter operative time, but there
was no difference in blood loss on an intention-to-treat
basis (ie, including EM converted-to-open cases in the
EM cohort). Isolated series also described beneﬁts from
EM for outcomes such as reduced transfusion requirements
and LOS. Although the three series are nonrandomized
and at high risk of bias, they do provide examples of a
broader applicability of EM to occurences of supra-aortic
trauma (eg, use in hemodynamically unstable patients and
stenting of transected vessels using combined antegrade-
retrograde snare techniques). Expert opinion has previ-
ously estimated that almost 50% of axillosubclavian injuries
might be amenable to EM, but such reports describe vessel
transection and hypotension as contraindications to EM,
and thus, it is possible that, with increasing operator expe-
rience, the proportion of injuries considered suitable for
EM will increase.13 Use of intraluminal balloon occlusion
as a temporizing hemostatic measure has been described in
this systematic review and may have applicability as a means
of damage control in the trauma setting prior to deﬁnitive
EM or OS.1 It is acknowledged that this systematic review
sought to include the major supra-aortic vessels (axillosub-
clavian, innominate, and common carotid) and that verte-
bral artery trauma was not speciﬁed in the searches.
Although 24 cases of vertebral artery trauma have been
included (as part of series describing the other injuries), it
is recognized that EM (embolization) has been described
in large series of vertebral artery trauma not included in
this review and is an accepted treatment modality.2 Simi-
larly, the utility of EM and the results of OS revealed by
this review are not applicable to distal axillary artery injuries
(where concerns have been raised about stent fracture
resulting from arm mobility) or cervical carotid injuries(where narrative review has suggested a postprocedural
stroke rate of 3.5% and a 10% stent occlusion rate).3
As expected, the largest amount of data related to OS
(2057 patients). The majority of lesions were noniatrogenic
penetrating injuries in predominantly young male patients
(many with cardiovascular instability), and thus, it can be
assumed that the study sample is representative of the pop-
ulation of interest. The pooled mortality rate of 12.4% (95%
CI, 9.9%-15.2%) compares favorably with estimates of 5%-
40% from narrative reviews, but must be interpreted with
caution given the suboptimal reporting of follow-up among
studies.3,5 It is likely that this mortality rate more closely
reﬂects in-hospital mortality rather than all-cause mortality.
No difference in mortality was found in subgroup analysis
between penetrating and blunt injury or between studies
published before and after the year 2000. The pooled ampu-
tation rate of 1.3% (95% CI, 0.8%-1.9%) excludes primary
amputation (4 of 38 cases) and amputation secondary
to brachial plexus injury (10 of 38 cases), and it is acknowl-
edged that the latter is particularly associated with
poor functional results and a signiﬁcant late amputation
rate.34,43 Pooled results from the articles on OS should
not be directly compared with those from the EM cohorts,
as not only are the patient groups imbalanced, but there will
be bias related to modern perioperative management (such
as prehospital trauma care and in-hospital critical care) in
favor of the EM series given that the OS series includes
several older articles.
This study has a number of strengths including confor-
mation to the Preferred Reporting Items for Systematic
Reviews and Meta-analyses reporting standards and the
inclusion of non-English-language articles which reduces
publication bias. In keeping with current opinion that arbi-
trarily scoring aspects of study quality is problematic,
quality markers were judged to be either present, absent,
or unclear.91 Furthermore, the assignment of high risk of
bias to all nonrandomized studies ensures that the quality
of the available evidence is not overstated. Limitations of
this systematic review are the restriction of case series to
those with more than 10 patients of at least one artery
type, which is arguably unjustiﬁed as sample size of case
series has not been shown to inﬂuence outcome.92 The
rationale for excluding smaller series was to collate the
experiences of centers with signiﬁcant experience rather
than those reporting isolated cases, but it is recognized
that this resulted in the exclusion of 130 series, each with
between ﬁve and 10 patients (16 of the 130 series
described EM). The use of all-cause mortality as the
primary outcome was necessary given the heterogeneous
reporting of outcomes, but it is acknowledged that this is
less useful than more speciﬁc metrics (such as in-hospital
death) which may better reﬂect mortality directly resulting
from the vascular injury.
Endovascular management is an emerging technology
in the treatment of thoracic outlet vascular injuries and
may confer beneﬁts in outcomes compared with OS. The
purported beneﬁts could relate to secondary outcomes
such as operative time and LOS rather than primary
Table V. Characteristics of studies describing only patients who underwent open surgery (OS)
Reference and year Country
No. of
patients
No. of
injuries a
Consecutive
patients?
Patient
age and
gender b
Type of
injury
Any iatrogenic
injuries?
Getzen et al,33
1972
United States 16 5 ax-sub
1 bch
13 car
UC UC 100% pen No
Sampson et al,34
1993
United States 11 11 ax-sub UC mean 28y/100% 100% blunt No
Saletta et al,35
1976
United States 14 14 car Yes UC 100% pen No
Lim et al,36
1979
United States 17 14 ax-sub
3 bch
UC med 30y/94% 94% pen
6% blunt
No
Richardson et al,37
1977
United States 22 19 ax-sub
3 bch
UC 13y-65y/73% 91% pen
9% blunt
No
Rich et al,38
1973
United States 65 65 ax-sub UC mean 22y/100% 100% pen No
Reynolds et al,39
1979
United States 39 29 ax-sub
2 bch
8 car
Yes UC 77% pen
18% blunt
5% iatro
Yes
O’Connor et al,40
2010
United States 36 23 ax-sub
1 bch
2 car
10 ven
Yes mean 28y/72% 100% pen No
McCready et al,41
1985
United States 40 39 ax-sub
1 ven
Yes mean 30y/87.5% 85% pen
15% blunt
No
Lin et al,42
2003
United States 54 54 ax-sub Yes mean 24y/87% 100% pen No
Johnson et al,43
1991
United States 23 25 ax-sub
4 ven
Yes UC 57% pen
43% blunt
UC
Hyre et al,44
1998
United States 35 30 ax-sub
5 ven
UC mean 28y/83% 80% pen
20% blunt
No
Weaver et al,45
1989
United States 46 25 ax-sub
5 bch
17 car
4 aa
UC mean 27y/98% 82% pen
14% blunt
4% iatro
Yes
Hoff et al,46
1994
United States 21 16 ax-sub
5 bch
UC mean 30y/90% 62% pen
38% blunt
No
McCoy et al,47
1997
United States 32 32 ax-sub Yes med 31y/91% 84% pen
13% blunt
3% iatro
Yes
Richardson et al,48
1982
United States 20 13 ax-sub
5 bch
5 car
3 vert
UC mean 23y/85% 100% blunt No
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Table V.
Trauma
score c Shock, d %
Sternotomy or
thoracotomy
used? e
Details of
treatment Outcomes f
Loss to follow-up/
follow-up period g Comments
NS NS NS 87.5% prim rep
6.25% vein recon
6.25% ligation
2/16 (12.5%) death
1/16 (6.25%) stroke
1/16 (6.25%) amp
NS/NS None
NS NS Yes 55% vein recon
18% ligation
9% resus thorac
18% non-op
0/11 (0%) death
0/11 (0%) stroke
1/11 (9%) amp
NS/mean 36m STD series, two
amputations
due to BPI
NS NS Yes 71% prim rep
14% vein recon
14% pros recon
4/14 (29%) death
0/14 (0%) stroke
0/14 (0%) amp
NS/NS Only carotid injuries
used as others
likely dual
published
NS 53% Yes 50% prim rep
44% vein recon
6% pros recon
1/17 (6%) death
0/17 (0%) stroke
0/17 (0%) amp
NS/NS None
NS 50% Yes 86% prim rep
9% vein recon
5% pros recon
1/22 (4.5%) death
0/22 (0%) stroke
0/22 (0%) amp
NS/NS None
NS 41% Yes 46% prim rep
17% vein recon
3% pros recon
15% ligation
8% resus thorac
11% NFS
7/65 (11%) death
0/65 (0%) stroke
0/65 (0%) amp
29%/NS None
NS 26% NS 54% prim rep
41% vein recon
2.5% pros recon
2.5% ligation
6/39 (15%) death
0/39 (0%) stroke
2/39 (5%) amp
NS/NS None
NS 56% Yes 27% prim rep
73% pros recon
0/36 (0%) death
0/36 (0%) stroke
0/36 (0%) amp
53%/mean 31m Series excludes
resuscitative
thoracotomy
NS 5% Yes 51% prim rep
46% vein recon
3% ligation
3/40 (7.5%) death
0/40 (0%) stroke
0/40 (0%) amp
17.5%/mean 33.9m One amputation due
to BPI
NS 39% Yes 70% prim rep
18.5% vein recon
5.5% pros recon
5.5% ligation
21/54 (39%) death
0/54 (0%) stroke
0/54 (0%) amp
57%/mean 7m None
mean ISS
17.4
NS NS 11% prim rep
65% vein recon
8% pros recon
8% ligation
8% non-op
2/23 (9%) death
0/23 (0%) stroke
0/23 (0%) amp
0%/mean 7.2m One amputation due
to BPI
mean ISS
15
20% Yes 30% prim rep
57% vein recon
10% pros recon
3% ligation
2/35 (6%) death
0/35 (0%) stroke
1/35 (3%) amp
17%/UC None
NS 35% Yes 63% prim rep
6% vein recon
25% pros recon
2% other
2% non-op
2% resus thorac
3/46 (6.5%) death
1/46 (2%) stroke
0/46 (0%) amp
NS/NS None
mean ISS
35.9
62% Yes 28.5% prim rep
38% pros recon
28.5% ligation
5% non-op
5/21 (24%) death
1/21 (5%) stroke
0/21 (0%) amp
NS/NS Two primary
amputations
performed
NS 19% Yes 37.5% prim rep
12.5% vein recon
34% pros recon
12.5% resus thorac
3% non-op
6/32 (19%) death
0/32 (0%) stroke
0/32 (0%) amp
UC/NS None
NS 10% Yes 31% prim rep
38% vein recon
19% pros recon
12% ligation
0/20 (0%) death
0/20 (0%) stroke
0/20 (0%) amp
0%/med 36m None
Continued.
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 2 Sinha et al 559
Reference and year Country
No. of
patients
No. of
injuries a
Consecutive
patients?
Patient
age and
gender b
Type of
injury
Any iatrogenic
injuries?
Flint et al,49
1973
United States 146 37 ax-sub
7 bch
36 car
6 vert
74 ven
Yes 10y-80y/UC 98% pen
2% blunt
No
Brawley et al,50
1970
United States 20 18 ax-sub
1 bch
1 ven
UC 4y-47y/95% 85% pen
15% blunt
No
Sitzmann et al,51
1984
United States 20 20 ax-sub No UC UC No
Pate et al,52
1964
United States 21 12 ax-sub
1 bch
8 car
No mean 31y/81% 100% pen No
Buscaglia et al,53
1987
United States 13 13 ax-sub Yes med 26y/100% 69% pen
31% blunt
No
Hewitt et al,54
1974
United States 74 33 ax-sub
2 bch
10 car
1 aa
28 ven
Yes mean 29y/NS 100% pen No
Amato et al,55
1969
United States 25 14 ax-sub
13 ven
Yes NS 100% pen No
Cox et al,56
1999
United States 56 56 ax-sub UC mean 31y/80% 55% pen
45% blunt
No
Dorsey et al,57
1986
United States 15 15 ax-sub UC mean 26y/80% 100% blunt No
George et al,58
1991
United States 63 6 bch
57 car
Yes mean 28y/78% 62% pen
38% blunt
UC
Graham et al,59
1980
United States 93 61 ax-sub
32 ven
UC mean 27y/95% 98% pen
2% blunt
No
Johnston et al,60
1993
United States 43 43 bch UC mean 38y/88% 79% pen
16% blunt
5% NFS
UC
Stenning et al,61
2005
United Kingdom 20 20 ax-sub UC mean 67y/UC 100% blunt UC
Shaw et al,62
1995
United Kingdom 15 15 ax-sub UC UC 27% pen
73% blunt
No
Apffelstaedt et al,15
1994
South Africa 51 20 ax-sub
19 car
12 vert
Yes UC 100% pen UC
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Trauma
score c Shock, d %
Sternotomy or
thoracotomy
used? e
Details of
treatment Outcomes f
Loss to follow-up/
follow-up period g Comments
NS 39% Yes 81% prim rep
2% vein recon
5% pros recon
12% ligation
11/146 (7.5%) death
2/146 (1.4%) stroke
1/146 (0.7%) amp
50%/UC Note large number
of isolated venous
injuries
NS 20% Yes 75% prim rep/pros
recon
5% vein recon
20% ligation
1/20 (5%) death
2/20 (10%) stroke
0/20 (0%) amp
NS/UC None
NS 50% Yes 80% prim rep
20% vein recon
1/20 (5%) death
0/20 (0%) stroke
0/20 (0%) amp
NS/NS None
NS 10% Yes 43% prim rep
5% pros recon
38% ligation
14% non-op
4/21 (19%) death
0/21 (0%) stroke
0/21 (0%) amp
NS/NS One amputation due
to BPI
NS 23% Yes 80% pros recon/vein
recon
20% NFS
3/21 (14%) death
0/21 (0%) stroke
0/21 (0%) amp
NS/NS 2/3 deaths in
patients who were
DOA
NS 50% Yes 74% prim rep
11% pros recon/vein
recon
15% ligation
7/74 (9%) death
2/74 (3%) stroke
0/74 (0%) amp
NS/NS One amputation due
to BPI
NS NS Yes 92% prim rep
4% vein recon
4% ligation
0/25 (0%) death
0/25 (0%) stroke
0/25 (0%) amp
NS/NS None
mean ISS
36.3
45% Yes 36% prim rep
25% vein recon
30% pros recon
2% ligation
5% resus thorac
2% non-op
12/56 (21%) death
0/56 (0%) stroke
3/56 (5%) amp
NS/NS None
mean ISS
32.3
47% Yes 47% prim rep
13% vein recon
27% pros recon
7% ligation
7% NFS
2/15 (13%) death
0/15 (0%) stroke
1/15 (7%) amp
NS/NS ISS derived from
duplicate
publication
NS NS NS 24% prim rep
19% pros recon
10% ligation
43% non-op
5% NFS
12/63 (19%) death
2/63 (3%) stroke
0/63 (0%) amp
UC/3wks-36months Only carotid/
innominate
injuries used as
subclavian injuries
likely dual
published
NS 55% Yes 59% prim rep
7% vein recon
15% pros recon
13% ligation
5% resus thorac
12/93 (13%) death
0/93 (0%) stroke
0/93 (0%) amp
69%/2m-36m None
NS 40% Yes 58% prim rep
30% pros recon
12% recon NFS
11/43 (26%) death
0/43 (0%) stroke
0/43 (0%) amp
NS/NS None
NS NS No 25% prim rep
65% vein recon
10% non-op
0/20 (0%) death
0/20 (0%) stroke
0/20 (0%) amp
0%/at least 24m Low energy injuries
only
NS NS No 7% prim rep
93% vein recon
0/15 (0%) death
0/15 (0%) stroke
0/15 (0%) amp
7%/UC Three amputations
due to BPI
NS NS Yes 39% prim rep
50% pros recon
11% ligation
0/51 (0%) death
1/51 (2%) stroke
0/51 (0%) amp
NS/NS Innominate artery
injuries excluded as
likely dual
published
Table V. Continued.
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Reference and year Country
No. of
patients
No. of
injuries a
Consecutive
patients?
Patient
age and
gender b
Type of
injury
Any iatrogenic
injuries?
Buchan et al,63
1995
South Africa 31 23 bch
11 car
UC UC 100% pen No
McKinley et al,17
2000
South Africa 260 260 ax-sub Yes mean 32y/89% 96% pen
4% blunt
No
Fulton et al,64
1996
South Africa 19 19 bch Yes mean 26y/89% 100% pen No
Sriussadaporn et al,65 Thailand 16 16 ax-sub UC UC UC No
Luccas et al,66
1979
Brazil 29 29 ax-sub UC UC 69% pen
31% blunt
No
Kroitzsch et al,67
1990
Austria 31 30 ax-sub
1 ven
UC NS 52% pen
48% blunt
No
Hafez et al,68
1984
France 12 12 bch Yes mean 47y/50% 100% iatro Yes
Creagh et al,69
1991
Ireland 18 18 ax-sub UC UC 28% pen
72% blunt
No
Fitchett et al,70
1969
Vietnam 13 2 bch
11 car
UC NS/100% 100% pen No
Kretz et al,71
1981
France 11 11 ax-sub UC mean 36y/82% 100% blunt No
Kieffer et al,72
1979
France 20 16 ax-sub
1 bch
3 car
UC mean 28y/80% 100% blunt No
Spieler et al,73
1975
Switzerland 22 22 ax-sub UC NS 100% blunt No
Svendsen et al,74
1972
Denmark 12 12 ax-sub UC NS 17% pen
83% blunt
No
Cheng et al,75
2001
China 32 15 ax-sub
2 bch
15 car
UC 20y-30y/75% 72% pen
12.5% blunt
15.5% NFS
No
Zhen et al,26
2007
China 12 12 ax-sub UC mean 23y/100% 83% pen
17% blunt
No
Loeprecht et al,77
1982
Germany 23 23 ax-sub UC UC 100% blunt No
Ebraheim et al,78
1988
Multicenter 15 15 ax-sub No mean 31.5y/93% 100% blunt No
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Trauma
score c Shock, d %
Sternotomy or
thoracotomy
used? e
Details of
treatment Outcomes f
Loss to follow-up/
follow-up period g Comments
NS UC Yes 48% prim rep
3% vein recon
35.5% pros recon
3% ligation
3% resus thorac
6.5% non-op
2/31 (6%) death
0/31 (0%) stroke
0/31 (0%) amp
NS/NS Subclavian injuries
excluded as likely
dual published
NS 23% Yes 43% prim rep
39% vein recon
9% pros recon
2% ligation
7% non-op
30/260 (12%) death
0/260 (0%) stroke
0/260 (0%) amp
94%/UC None
NS 32% Yes 95% prim rep
5% pros recon
1/19 (5%) death
1/19 (5%) stroke
0/19 (0%) amp
NS/NS None
NS UC Yes 13% prim rep
81% vein recon
6% ligation
1/16 (6%) death
0/16 (0%) stroke
0/16 (0%) amp
NS/NS None
NS 48% Yes 28% prim rep
31% vein recon
24% pros recon
7% ligation
7% non-op
3% NFS
3/29 (10%) death
0/29 (0%) stroke
1/29 (3%) amp
NS/NS None
NS NS NS 10% prim rep
79% vein recon
10% pros recon
4/31 (13%) death
0/31 (0%) stroke
1/31 (3%) amp
0%/NS Three primary
amputations
NS NS Yes 50% prim rep
42% recon NFS
8% non-op
8/12 (67%) death
0/12 (0%) stroke
0/12 (0%) amp
NS/NS Innominate artery
erosion from
tracheostomy
NS NS NS 100% vein recon 3/18 (17%) death
0/18 (0%) stroke
2/18 (11%) amp
NS/NS None
NS 8% Yes 69% prim rep
15% vein recon
8% pros recon
8% resus thorac
4/13 (31%) death
1/13 (8%) stroke
0/13 (0%) amp
92%/UC None
NS NS Yes 45% prim rep
45% vein recon
9% pros recon
2/11 (18%) death
0/11 (0%) stroke
1/11 (9%) amp
NS/NS None
NS UC Yes 5% prim rep
45% vein recon
10% pros recon
20% ligation
20% non-op
5/20 (25%) death
1/20 (5%) stroke
1/20 (5%) amp
NS/NS None
NS NS NS 32% prim rep
55% vein recon
14% pros recon
4/22 (18%) death
0/22 (0%) stroke
0/22 (0%) amp
NS/NS None
NS 50% Yes 67% prim rep
33% pros recon
3/12 (25%) death
0/12 (0%) stroke
0/12 (0%) amp
NS/NS None
NS 16% Yes 65% prim rep
6% pros recon
10% vein recon
19% recon NFS
7/32 (22%) death
0/32 (0%) stroke
0/32 (0%) amp
NS/NS None
NS 17% No 58% prim rep
25% vein recon
17% pros recon
0/12 (0%) death
0/12 (0%) stroke
0/12 (0%) amp
NS/mean 62m None
NS NS No 48% prim rep
52% vein recon or
pros recon
2/23 (9%) death
0/23 (0%) stroke
2/23 (9%) amp
NS/NS None
NS 67% NS 80% prim rep
20% non-op
3/15 (20%) death
0/15 (0%) stroke
1/15 (7%) amp
NS/NS STD series
Table V. Continued.
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Reference and year Country
No. of
patients
No. of
injuries a
Consecutive
patients?
Patient
age and
gender b
Type of
injury
Any iatrogenic
injuries?
Fitridge et al,79
1994
Australia 28 28 ax-sub No med 31y/93% 21% pen
79% blunt
UC
Aksoy et al,80
2005
Turkey 38 38 ax-sub Yes mean 30y/92% 66% pen
34% blunt
No
Stein et al,81
1974
South Africa 29 25 ax-sub
8 car
3 vert
UC UC 100% pen No
Demetriades et al,16
1987
South Africa 90 62 ax-sub
28 ven
Yes mean 26y/93% 100% pen No
Degiannis et al,82
1994
South Africa 76 62 ax-sub
14 ven
UC mean 31y/96% 100% pen No
Cikrit et al,83
1990
United States 13 13 ax-sub Yes UC 85% pen
15% blunt
No
Klein et al,84
1988
United States 46 46 ax-sub UC 13y-66y/72% 76% pen
24% blunt
No
aa, Ascending aorta/aortic arch; ax-sub, axillo-subclavian; bch, brachiocephalic/innominate; BPI, brachial plexus injury; car, carotid; death, all-cause death;
DOA, dead on arrival; iatro, iatrogenic; ISS, Injury Severity Score; NFS, not further speciﬁed; non-op, nonoperative management; NS, not stated; pen,
penetrating; prim rep, primary repair; pros recon, reconstruction with prosthetic material; resus thorac, resuscitative thoracotomy or sternotomy only; STD,
scapulo-thoracic dissociation; UC, unclear; vein recon, reconstruction with vein; ven, isolated venous injury; vert, vertebral.
aRefers to primary injury as deﬁned by authors.
bMean, median, or range for age (years) as speciﬁed by the authors, gender given as male proportion (%).
cHowever deﬁned by the authors (mean or median).
dShock or hemodynamic instability—however deﬁned by the authors.
eScored as “yes” if sternotomy or thoracotomy was used for any of the OS cases.
fAll outcomes analyzed as intention-to-treat, stroke includes only new postoperative stroke, amputation (amp) excludes that explicitly described as secondary
to neurological sequelae of brachial plexus injury and primary amputation for trauma.
gLoss to follow-up given as proportion (%), follow-up period given as mean or median (weeks or months) (however stated by authors).
Table V. Characteristics of studies describing only patients who underwent open surgery (OS)
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by a need for increased postoperative surveillance. There
are no randomized trials or high-quality studies comparing
EM with OS at present. The current evidence level is weak
and fails to show superiority of one modality over the
other. EM is currently used primarily in highly selected
cases (stable patients with arteriovenous ﬁstulas or false
aneurysms or in those with iatrogenic injuries), but there
are reported cases which demonstrate a broader applica-
bility in trauma. In particular, sporadic reports challenge
the traditional surgical dogma that hemodynamically
unstable patients with supra-aortic trauma are best served
by immediate thoracotomy and arterial clamping rather
than by femoral artery access and aortic balloon occlusion.
Although such a statement may seem controversial, one
need only consider studies such as the IMPROVE trial,
which is currently randomizing patients with ruptured
abdominal aortic aneurysms to either endovascular aneu-
rysm repair or OS.93 Hemodynamic instability should not
be considered a contraindication to EM, but this approachmay be feasible only in modern vascular centers, which
offer adequate infrastructure (such as hybrid interventional
theaters and 24-hour availability of personnel with endo-
vascular skills).
High-quality studies (eg, randomized trials) or large-
scale registry data are needed to comment further on the
relative merits or disadvantages of EM in comparison to
OS and to determine which patients and anatomical conﬁg-
urations of injury will most beneﬁt from EM.AUTHOR CONTRIBUTIONS
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Trauma
score c Shock, d %
Sternotomy or
thoracotomy
used? e
Details of
treatment Outcomes f
Loss to follow-up/
follow-up period g Comments
NS NS Yes 12% prim rep
31% vein recon
4% pros recon
15% ligation
38% non-op
2/28 (7%) death
0/28 (0%) stroke
2/28 (7%) amp
UC/mean 16.4m Two primary
amputations
NS 29% Yes 42% prim rep
45% vein recon
13% ligation
2/38 (5%) death
0/38 (0%) stroke
0/38 (0%) amp
64%/mean 7m One amputation due
to BPI
NS UC NS 79% prim rep
17% ligation
4% NFS
4/38 (11%) death
0/38 (0%) stroke
1/38 (3%) amp
NS/NS None
NS 72% Yes 56% prim rep
21% vein recon
6% pros recon
18% ligation
11/90 (12%) death
2/90 (2%) stroke
0/90 (0%) amp
NS/NS None
NS 96% Yes 55% prim rep
12.5% vein recon
29% pros recon
4% ligation
25/76 (33%) death
0/76 (0%) stroke
0/76 (0%) amp
71%/med 1m None
NS NS NS 15% prim rep
54% vein recon
31% ligation
0/13 (0%) death
0/13 (0%) stroke
0/13 (0%) amp
UC/UC None
NS 13% Yes 41% prim rep
57% vein recon
2% ligation
2/46 (4%) death
0/46 (0%) stroke
0/46 (0%) amp
76%/6m None
Table V. Continued.
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Supplementary Table I (online only). Example of Medline search performed on 1/11/2011
Search terms Hits
1. “subclavian”.mp. or exp Subclavian Artery/ or exp Subclavian Vein/ 15,854
2. “supra-aortic”.mp. or exp Brachiocephalic Trunk/ 2679
3. “supraaortic”.mp. 310
4. *aorta, thoracic/ or *axillary artery/ or *brachiocephalic trunk/or *subclavian artery/ or *thoracic arteries/ 18,942
5. *upper extremity/ or *arm/ or *axilla/ or *shoulder/ 18,796
6. “wounds and injuries"/ or exp amputation, traumatic/ or exp contusions/or exp dislocations/or exp fractures,
bone/or exp multiple trauma/or exp neck injuries/ or exp rupture/ or exp shock, traumatic/or exp soft
tissue injuries/ or exp thoracic injuries/or exp vascular system injuries/ or exp wounds, nonpenetrating/or
exp wounds, penetrating/
299,487
7. “laceration*”.mp. 8524
8. “transection*”.mp. 14,590
9. “puncture*”.mp. 37,774
10. 6 or 7 or 8 or 9 354,533
11. 1 or 2 or 3 or 4 or 5 49,147
12. 10 and 11 5006
13. Remove duplicates from 12 4922
Supplementary Table II (online only). Results of quality assessment for studies describing both open surgery (OS) and
endovascular management (EM) (n ¼ 15)a
Criterion Yes No Unclear
1. Were participants a representative sample selected from a relevant patient population? 15 0 0
2. Were inclusion/exclusion criteria for participants clearly described? 13 2 0
3. Were participants entering the study at a similar point in their disease progression? 2 8 5
4. Were the groups comparable on demographic characteristics and clinical features? 3 12 0
5. Was the recruitment period clearly stated? 14 1 0
6. Was the intervention (and comparison) that which is being considered in the review? 15 0 0
7. Was an attempt made to blind study participants to the intervention they received? 0 15 0
8. Was an attempt made to blind outcome assessors? 0 15 0
9. Were the procedures undertaken by an experienced operator? 1 0 14
10. Did the staff, place, and facilities where the patients were treated provide an appropriate environment for
performing the procedure?
11 0 4
11. Were objective (valid and reliable) outcome measures used? 15 0 0
12. Were all the important outcomes considered? 12 3 0
13. Was follow-up long enough to detect important effects on outcomes of interest? 5 2 8
14. Was information provided on nonrespondents and dropouts? 5 10 0
15. Were participants lost to follow-up likely to introduce bias? 0 4 11
16. Were all important confounding factors identiﬁed? 3 12 0
17. Were confounding factors taken into account in the analyses? 0 15 0
aNote that when scoring each study, 1 point is given for “yes” and 0 points is given for “no” or “unclear,” except for question 15, where 1 point is given for
“no” and 0 points is given for “yes” or “unclear.”
JOURNAL OF VASCULAR SURGERY
567.e1 Sinha et al February 2013
Supplementary Table III (online only). Results of quality assessment for studies describing only endovascular
management (EM) (n ¼ 4)a
Criterion Yes No Unclear
1. Were participants a representative sample selected from a relevant patient population? 4 0 0
2. Were inclusion/exclusion criteria for participants clearly described? 4 0 0
3. Were participants entering the study at a similar point in their disease progression? 2 1 1
4. Was selection of patients consecutive? 0 4 0
5. Were all important prognostic factors identiﬁed? 1 2 1
6. Was data collection undertaken prospectively? 2 2 0
7. Was the recruitment period clearly stated? 4 0 0
8. Was the intervention that which is being considered in the review? 4 0 0
9. Were the procedures undertaken by an experienced operator? 0 0 4
10. Did the staff, place, and facilities where the patients were treated provide an appropriate environment
for performing the procedure?
4 0 0
11. Were objective (valid and reliable) outcome measures used? 3 1 0
12. Were all the important outcomes considered? 2 2 0
13. Was follow-up long enough to detect important effects on outcomes of interest? 3 0 1
14. Was information provided on nonrespondents and dropouts? 4 0 0
15. Were participants lost to follow-up likely to introduce bias? 1 2 1
16. Were the main ﬁndings clearly described? 4 0 0
aNote that when scoring each study, 1 point is given for “yes” and 0 points is given for “no” or “unclear,” except for Question 15, where 1 point is given for
“no” and 0 points is given for “yes” or “unclear.”
Supplementary Table IV (online only). Results of quality assessment for studies describing only open surgery (OS)
(n ¼ 55)a
Criterion Yes No Unclear
1. Were participants a representative sample selected from a relevant patient population? 55 0 0
2. Were inclusion/exclusion criteria for participants clearly described? 35 20 0
3. Were participants entering the study at a similar point in their disease progression? 15 14 26
4. Was selection of patients consecutive? 19 4 32
5. Were all important prognostic factors identiﬁed? 37 17 1
6. Was data collection undertaken prospectively? 3 52 0
7. Was the recruitment period clearly stated? 48 7 0
8. Was the intervention that which is being considered in the review? 55 0 0
9. Were the procedures undertaken by an experienced operator? 3 0 52
10. Did the staff, place, and facilities where the patients were treated provide an appropriate environment
for performing the procedure?
22 0 33
11. Were objective (valid and reliable) outcome measures used? 46 9 0
12. Were all the important outcomes considered? 43 12 0
13. Was follow-up long enough to detect important effects on outcomes of interest? 11 5 39
14. Was information provided on nonrespondents and dropouts? 15 39 1
15. Were participants lost to follow-up likely to introduce bias? 3 3 49
16. Were the main ﬁndings clearly described? 55 0 0
aNote when scoring each study, 1 point given for “yes” and 0 points given for “no” or “unclear” except for Q15 when 1 point given for “no” and 0 points
given for “yes” or “unclear.”
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Supplementary Table V (online only). Summary of ﬁndings table for primary outcome (all-cause mortality) from
studies reporting both open surgery (OS) and endovascular management (EM)
Question: Should EM versus OS be used for patients with thoracic outlet vascular trauma?
Quality assessment
Participants
(studies) follow-up Risk of bias Inconsistency Indirectness Imprecision Publication bias
Overall quality of
evidence
All-cause mortalitya (CRITICAL OUTCOME; assessed with: dichotomous outcome measured per number of patients)
48 (15 studiesb,c) Seriousd Seriouse No serious
indirectness
Seriousf Reporting bias strongly
suspectedg
4222 Very lowd-h due
to risk of bias,
inconsistency, imprecision,
publication bias, plausible
counfounding would
change the effect
CI, Conﬁdence interval; OR, odds ratio.
aPooled results for comparison only performed for only three studies that described broadly comparable cohorts of OS and EM patients (Carrick et al,23
Shalhub et al,4 Xenos et al21).
bFifteen retrospective studies describing outcomes after both OS and EM (549 patients) of which three studies described comparable groups (48 patients).
cOnly three studies described comparable groups undergoing OS and EM (Carrick et al,23 Shalhub et al,4 Xenos et al21).
dNo study scored maximum on checklist criteria and particular deﬁciencies related to lack of blinding of outcomes assessors, baseline imbalance and incomplete
follow-up reporting.
eForest plot and statistical tests for meta-analysis of proportions did suggest evidence of heterogeneity among the 15 studies.
fMeta-analysis of mortality between the three studies describing comparable OS and EM cases is hampered by small numbers and too few events which
consequently generates an effect estimate with a wide CI.
gFunnel plot and Egger test did suggest evidence of publication bias for the 15 studies.
hNone of the studies carried out any form of case-mix adjustment in analyses. Given the retrospective nature of the studies, confounding factors (such as
patient demographics and disease severity) cannot be excluded.
iBased on the three studies with comparable OS and EM cohorts.
jFavors open surgery.
kControl risk based on results of meta-analysis of proportions for mortality rates amongst studies (n ¼ 55) describing only open surgery.
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Summary of ﬁndings
Study event rates (%)
Relative effect (95% CI)
Anticipated absolute effects
With OS With EM Risk with OS Risk difference with EM (95% CI)
2/23 (8.7%)i 5/25 (20%)i OR 0.67
(0.11-4.05)j
Study populationk
87 mortalities
per 1000i
27 fewer mortalities per 1000
(from 77 fewer to 191 more)
Moderatek
124 mortalities
per 1000i
37 fewer mortalities per 1000
(from 109 fewer to 240 more)
Supplementary Table V (online only). Continued.
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Supplementary Table VI (online only). Summary of ﬁndings table for primary outcome (all-cause mortality) from
studies reporting only endovascular management (EM)
Question: Should EM be used for patients with thoracic outlet vascular trauma?
Quality assessment
Participants (studies)
Follow up Risk of bias Inconsistency Indirectness Imprecision
Publication
bias
Overall quality
of evidence
All-cause mortality (CRITICAL OUTCOME; assessed with: dichotomous outcome measured per number of patients)
101 (four studiesa)
14.8-49 monthsh
Seriousb No serious
inconsistencyc
Seriousd Seriouse Undetectedf 4222
VERY LOWb-f
due to risk of bias,
indirectness,
imprecision
CI, Conﬁdence interval.
aOne industry-sponsored, nonrandomized, noncomparative prospective study and three retrospective case series with more than 10 patients for at least one
type of artery.
bProspective study was nonrandomized and industry-sponsored. None of the retrospective series scored maximum points on quality checklist with particular
deﬁciencies related to nonconsecutive patient selection and lack of information on operator experience.
cAlthough statistical tests suggested heterogeneity, there was reasonable overlap of conﬁdence intervals and heterogeneity was reduced when pooled analysis
was restricted to the three studies describing iatrogenic injuries.
dThree out of four studies described either entirely or predominantly iatrogenic injuries.
eFour studies provided only 101 patients (with only 19 deaths) and consequently pooled analysis generated a wide CI.
fEgger test did not suggest publication bias although it is noted that there were only four studies.
gOf the 19 reported deaths, three were reported within 30 days but it is noteworthy that none of the 19 deaths were explicitly linked to the vascular injury or
subsequent EM by the studies’ authors.
hValues given are mean lengths of follow-up from the three retrospective case series. The prospective study reported survival analysis.
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Summary of ﬁndings
Study event rates (%)
Relative effect (95% CI)
Anticipated absolute effects
With control With EM Risk with control Risk difference with EM (95% CI)
— 19/101 (18.8%)g — See commentsa-h See commentsa-h
Supplementary Table VI (online only). Continued.
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Supplementary Table VII (online only). Summary of ﬁndings table for primary outcome (all-cause mortality) from
studies reporting only open surgery (OS)
Question: Should OS be used for patients with thoracic outlet vascular trauma?
Quality assessment
Participants (studies)
follow-up Risk of bias Inconsistency Indirectness Imprecision Publication bias
Overall quality of
evidence
All-cause mortality (CRITICAL OUTCOME; assessed with: dichotomous outcome measured per number of patients)
2057 (55 studiesa),
7.2-36 monthsb
Seriousc Seriousd No serious
indirectness
No serious
imprecisione
Reporting bias
strongly suspectedf
4222 Very lowc-f
due to risk of bias,
inconsistency,
publication bias
CI, Conﬁdence interval.
aFifty-ﬁve retrospective case series each with more than 10 patients for at least one type of artery (a total of 2057 patients).
bOnly three studies described 100% follow-up over deﬁned periods. In 80% of studies the length of follow-up was either not clear or too short to exclude
important effects on outcomes, whereas 70% of studies did not provide attrition rates.
cNo study scored maximum points on quality checklist and particular deﬁciencies related to incomplete follow-up and lack of information on operator
experience.
dAlthough there was reasonable overlap of CIs for pooled analysis, statistical testing indicates signiﬁcant study heterogeneity was present.
eThe 55 studies described 2057 patients with 267 events (death) and this generates a correspondingly narrow 95% CI for pooled mortality.
fFunnel plot and Egger test both suggested that publication bias was present.
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Summary of fndings
Study event rates (%)
Relative effect (95% CI)
Anticipated absolute effects
With control With OS
Risk with
control Risk difference with OS (95% CI)
— 267/2057 (13.0%) — See commentsa-f See commentsa-f
Supplementary Table VII (online only). Continued.
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